354. Effects of psilocybin treatment on cognitive function in Japanese patients with treatment-resistant depression: an open-label study
International Journal of Neuropsychopharmacology September 9, 2026 S Tomiyama, K Yonezawa, K Kusudo et al.
Abstract Background Cognitive dysfunction is associated with impaired psychosocial functioning in patients with major depressive disorder (MDD). Patients with treatment-resistant depression (TRD) exhibit more pronounced cognitive dysfunction than those with non-resistant MDD, underscoring the need for effective therapeutic strategies. Psilocybin has emerged as a promising treatment for...